Healthcare -
Biotechnology - NASDAQ - US
$ 46.86
-4.01 %
$ 2.02 B
Market Cap
-10.7
P/E
SLNO - OTHER FINANCING ACTIVITIES
Other Financing Activities SLNO - Soleno Therapeutics, Inc.
42.2 M
LAST VALUE
1779.76%
2 YEAR CAGR
94.24%
5 YEAR CAGR
0.00%
10 YEAR CAGR